361 related articles for article (PubMed ID: 9338094)
1. Control of the G1/S transition.
Reed SI
Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
[TBL] [Abstract][Full Text] [Related]
2. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the activity of cyclin-kinase complexes governing cell transition from G1 phase to DNA replication phase in E1A + c-Ha-ras transformants transfected with the bcl-2 gene].
Neliudova AM; Aksenov ND; Pospelova TV
Tsitologiia; 2003; 45(2):149-57. PubMed ID: 12722479
[TBL] [Abstract][Full Text] [Related]
5. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
6. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
Sarcevic B; Lilischkis R; Sutherland RL
J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
[TBL] [Abstract][Full Text] [Related]
7. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
Poolman RA; Brooks G
J Mol Cell Cardiol; 1998 Oct; 30(10):2121-35. PubMed ID: 9799664
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-regulated G1 cyclins.
Sherr CJ
Stem Cells; 1994; 12 Suppl 1():47-55; discussion 55-7. PubMed ID: 7696969
[TBL] [Abstract][Full Text] [Related]
9. Regulation by transforming growth factor-beta 1 of G1 cyclin-dependent kinases in human retinal epithelial cells.
Pillaire MJ; Casagrande F; Malecaze F; Manenti S; Darbon JM
Exp Eye Res; 1999 Feb; 68(2):193-9. PubMed ID: 10068484
[TBL] [Abstract][Full Text] [Related]
10. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
11. Control of G1 progression by D-type cyclins: key event for cell proliferation.
Kato JY
Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
[TBL] [Abstract][Full Text] [Related]
12. [Cell cycle and parathyroid tumor].
Matsushime H
Nihon Rinsho; 1995 Apr; 53(4):844-9. PubMed ID: 7752470
[TBL] [Abstract][Full Text] [Related]
13. [Control mechanisms of cell transition from the G1 phase to the S phase--the R point].
Bártek J; Lukás L; Strauss M
Cas Lek Cesk; 1996 Oct; 135(19):634-5. PubMed ID: 8998807
[TBL] [Abstract][Full Text] [Related]
14. Regulators of G1 cyclin-dependent kinases and cancers.
Lee MH; Yang HY
Cancer Metastasis Rev; 2003 Dec; 22(4):435-49. PubMed ID: 12884917
[TBL] [Abstract][Full Text] [Related]
15. Active RB elicits late G1/S inhibition.
Angus SP; Fribourg AF; Markey MP; Williams SL; Horn HF; DeGregori J; Kowalik TF; Fukasawa K; Knudsen ES
Exp Cell Res; 2002 Jun; 276(2):201-13. PubMed ID: 12027450
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclin-dependent kinases by p21.
Harper JW; Elledge SJ; Keyomarsi K; Dynlacht B; Tsai LH; Zhang P; Dobrowolski S; Bai C; Connell-Crowley L; Swindell E
Mol Biol Cell; 1995 Apr; 6(4):387-400. PubMed ID: 7626805
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of retinoblastoma-related protein by the cyclin D/cyclin-dependent kinase complex is activated at the G1/S-phase transition in tobacco.
Nakagami H; Kawamura K; Sugisaka K; Sekine M; Shinmyo A
Plant Cell; 2002 Aug; 14(8):1847-57. PubMed ID: 12172026
[TBL] [Abstract][Full Text] [Related]
18. Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates.
Suryadinata R; Sadowski M; Sarcevic B
Biosci Rep; 2010 Mar; 30(4):243-55. PubMed ID: 20337599
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
Akli S; Keyomarsi K
Cancer Biol Ther; 2003; 2(4 Suppl 1):S38-47. PubMed ID: 14508079
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
